These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 12650099)
1. [Current principles of treatment of acid-dependent diseases]. Maev IV; V'iuchnova ES; Grishchenko EB Klin Med (Mosk); 2003; 81(1):56-62. PubMed ID: 12650099 [TBL] [Abstract][Full Text] [Related]
2. Impact of acid-related disorders in the United States. Brown M; Yang RD Manag Care; 2001 Oct; 10(10 Suppl):7-10. PubMed ID: 11729446 [TBL] [Abstract][Full Text] [Related]
3. [25 years of gastric acid blockers]. Lamers CB Ned Tijdschr Geneeskd; 1999 Dec; 143(50):2501-4. PubMed ID: 10627749 [TBL] [Abstract][Full Text] [Related]
4. [H2 blockers and antacids in gastrointestinal diseases]. Stein J; Rösch W Pharm Unserer Zeit; 2007; 36(1):38-43. PubMed ID: 17283749 [No Abstract] [Full Text] [Related]
5. [Clinical importance of antagonists of histamine H2 receptors in gastroenterology]. Carella G Clin Ter; 1984 Mar; 108(6):525-9. PubMed ID: 6144411 [No Abstract] [Full Text] [Related]
6. Over-the-counter histamine H2-receptor antagonists. How will they affect the treatment of acid-related diseases? Holt S Drugs; 1994 Jan; 47(1):1-11. PubMed ID: 7510616 [No Abstract] [Full Text] [Related]
7. The use and abuse of histamine H2-receptor antagonists. Milton-Thompson GJ J R Nav Med Serv; 1977; 63(1):9-14. PubMed ID: 17005 [No Abstract] [Full Text] [Related]
8. Omeprazole in the treatment of Zollinger-Ellison syndrome and histamine H2-antagonist refractory ulcers. Meijer JL; Jansen JB; Lamers CB Digestion; 1989; 44 Suppl 1():31-9. PubMed ID: 2575060 [TBL] [Abstract][Full Text] [Related]
9. Dyspepsia responsive to acid suppression therapy: reflux disease or duodenal hypersensitivity? Smout AJ Dig Liver Dis; 2000 Dec; 32 Suppl 3():S258-60. PubMed ID: 11245313 [No Abstract] [Full Text] [Related]
10. [Peptic ulcer: current therapy]. Pieragnoli E G Clin Med; 1987 Apr; 68(4):197-209. PubMed ID: 2886387 [No Abstract] [Full Text] [Related]
11. H2-receptor antagonists in perspective. Malagelada JR; Cortot A Mayo Clin Proc; 1978 Mar; 53(3):184-90. PubMed ID: 24155 [TBL] [Abstract][Full Text] [Related]
12. Dyspepsia and reflux in primary care: rough DIAMOND of a trial. van Zanten SV Lancet; 2009 Jan; 373(9659):187-8. PubMed ID: 19150689 [No Abstract] [Full Text] [Related]
13. [Anti-ulcer drugs. Indications in adults. French Agency of the Safety of Health Products]. Presse Med; 2000 Jan; 29(2):86-94. PubMed ID: 10682037 [No Abstract] [Full Text] [Related]
14. [Management of the hypersecretion of acid in Zollinger-Ellison syndrome (ZES)]. Varas MJ; López A; Gordillo J Rev Esp Enferm Apar Dig; 1989 Apr; 75(4):419-20. PubMed ID: 2568007 [No Abstract] [Full Text] [Related]
15. Recent advances in the management of gastric acid hypersecretion in patients with Zollinger-Ellison syndrome. Maton PN; Gardner JD; Jensen RT Gastroenterol Clin North Am; 1989 Dec; 18(4):847-63. PubMed ID: 2575602 [TBL] [Abstract][Full Text] [Related]
16. [Treatment of stomach ulcer and of Zollinger-Ellison syndrome with cimetidine]. Brunner H Acta Med Austriaca; 1978; 5(2):36-40. PubMed ID: 735716 [TBL] [Abstract][Full Text] [Related]
17. Gastroesophageal reflux disease: current treatment approaches. Biddle W Director; 2003; 11(4):155-9. PubMed ID: 14608699 [No Abstract] [Full Text] [Related]